Divis Lab Q1 PAT seen up 27.3% YoY to Rs 709 cr: ICICI Direct

ICICI Direct has come out with its first quarter (April-June’ 22) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Divis Lab to report net profit at Rs 709 crore up 27.3% year-on-year (down 20.7% quarter-on-quarter).

Net Sales are expected to increase by 18 percent Y-o-Y (down 8.1 percent Q-o-Q) to Rs 2,314.5 crore, according to ICICI Direct.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 16.7 percent Y-o-Y (down 10 percent Q-o-Q) to Rs 994.1 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.